Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Interest Expenses (2018 - 2025)

TransMedics has reported Interest Expenses over the past 8 years, most recently at $3.4 million for Q4 2025.

  • Quarterly results put Interest Expenses at $3.4 million for Q4 2025, down 6.08% from a year ago — trailing twelve months through Dec 2025 was $13.8 million (down 4.35% YoY), and the annual figure for FY2025 was $13.8 million, down 4.35%.
  • Interest Expenses for Q4 2025 was $3.4 million at TransMedics, down from $3.5 million in the prior quarter.
  • Over the last five years, Interest Expenses for TMDX hit a ceiling of $3.6 million in Q2 2024 and a floor of $787000.0 in Q3 2022.
  • Median Interest Expenses over the past 5 years was $2.9 million (2023), compared with a mean of $2.3 million.
  • Biggest five-year swings in Interest Expenses: fell 19.61% in 2022 and later skyrocketed 356.16% in 2023.
  • TransMedics' Interest Expenses stood at $978000.0 in 2021, then increased by 2.97% to $1.0 million in 2022, then surged by 257.99% to $3.6 million in 2023, then decreased by 0.94% to $3.6 million in 2024, then dropped by 6.08% to $3.4 million in 2025.
  • The last three reported values for Interest Expenses were $3.4 million (Q4 2025), $3.5 million (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.